|
|
|
42
|
5274AA
|
LYRICA 150MG CAP (PFI) PREGABALIN
|
PREGABALIN
|
LYRICA
|
28'S
|
C
|
102.40
|
3.66
|
CAP
|
120
|
BLIS
|
PFI
|
PFIZER CORPORATION
|
COL
|
AVENTA BARBADOS
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
41
|
5274N
|
PREGASAFE 150MG CAP (MSN) PREGABALIN (B)
|
PREGABALIN
|
PREGASAFE
|
3X10
|
B
|
5.44
|
0.1812
|
CAP
|
120
|
BOX
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
5274P
|
PREGABALIN 150MG TAB (MCP/AHI)
|
PREGABALIN
|
PREGABALIN
|
3X10
|
B
|
5.57
|
0.19
|
TABLET
|
0
|
TAB
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
52761
|
LYRICA 300MG TAB (PFI/STO) PREGABALIN
|
PREGABALIN
|
LYRICA
|
28'S
|
C
|
153.59
|
5.49
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
52761
|
LYRICA 300MG TAB (PFI) PREGABALIN (C)
|
PREGABALIN
|
LYRICA
|
28'S
|
C
|
154.97
|
5.5347
|
TAB
|
60
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
52763
|
LYRICA 300MG TAB (PFI/SBI) PREGABALIN
|
PREGABALIN
|
LYRICA
|
28'S
|
C
|
153.59
|
5.49
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
52763
|
LYRICA 300MG TAB (PFI) PREGABALIN (C)
|
PREGABALIN
|
LYRICA
|
28'S
|
C
|
154.97
|
5.5347
|
TAB
|
60
|
BOX
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
52764
|
APO-PREGABALIN 300MG CAP (APO/COL)
|
PREGABALIN
|
APO-PREGABALIN
|
100'S
|
B
|
59.80
|
0.60
|
CAPSULE
|
0
|
CAP
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
52765
|
PMS-PREGABALIN 300MG CAP (PMS) (B)
|
PREGABALIN
|
PMS-PREGABALIN
|
100'S
|
B
|
31.8
|
0.318
|
CAP
|
60
|
BOTT
|
PMS
|
PHARMASCIENCE
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
42
|
52765
|
PMS-PREGABALIN 300MG CAP (PMS)
|
PREGABALIN
|
PMS-PREGABALIN
|
100'S
|
C
|
24.46
|
0.24
|
CAP
|
60
|
BOTT
|
PMS
|
PHARMASCIENCE
|
COL
|
AVENTA BARBADOS
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
52816
|
FUCITHALMIC 1% EYE DR (ANT/COL) FUSIDIC ACID
|
FUSIDIC ACID
|
FUCITHALMIC
|
5G
|
A
|
14.95
|
14.95
|
EYE DROP
|
1
|
TUBE
|
ANT
|
CONCORDIA INTERNATIONAL
|
COL
|
COLLINS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
42
|
52816
|
FUCITHALMIC 1% EYE DR (ANT) FUSIDIC ACID
|
FUSIDIC ACID
|
FUCITHALMIC
|
5G
|
A
|
8.83
|
8.83
|
TUBE
|
1
|
BOX
|
ANT
|
CONCORDIA INTERNATIONAL
|
COL
|
AVENTA BARBADOS
|
|
520404
|
EENT ANTIBACTERIALS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
40
|
5281AA
|
VISAG 0.1% EYE DR (LPO/COL) AZITHROMYCIN
|
AZITHROMYCIN
|
VISAG
|
2.5ML
|
BQ
|
8.43
|
8.43
|
EYE DROP
|
0
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
5281AA
|
VISAG 0.1% EYE DR (LPO) AZITHROMYCIN (BQ)
|
AZITHROMYCIN
|
VISAG
|
2.5ML
|
BQ
|
8.43
|
8.4268
|
BOTT
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
42
|
5281AA
|
VISAG 0.1% EYE DR (LPO) AZITHROMYCIN
|
AZITHROMYCIN
|
VISAG
|
2.5ML
|
BQ
|
20.39
|
20.39
|
BOTT
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
AVENTA BARBADOS
|
|
520404
|
EENT ANTIBACTERIALS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
40
|
5281BB
|
MOXICIP 0.5% EYE DR (CIP/AHI) MOXIFLOXACIN
|
MOXIFLOXACIN
|
MOXICIP
|
5ML
|
BQ
|
10.60
|
10.60
|
EYE DROP
|
0
|
BOTT
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2022-09-30
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2022-03-29
|
|
|
|
40
|
5281BK
|
GATIF FORTE 0.3% DROPS (LPO/COL) GATIFLOXACIN
|
GATIFLOXACIN
|
GATIF FORTE
|
5ML
|
C
|
9.51
|
9.51
|
DROPS
|
0
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
5281BK
|
GATIF FORTE 0.3% EYE DR (LPO) GATIFLOXACIN (C)
|
GATIFLOXACIN
|
GATIF FORTE
|
5ML
|
C
|
10.47
|
10.4655
|
BOTT
|
0
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
42
|
5281BU
|
CIPROFLOXACIN 0.3% EYE DR (CIP)
|
CIPROFLOXACIN
|
CIPROFLOXACIN
|
10ML
|
BQ
|
1.25
|
1.25
|
BOTT
|
0
|
BOX
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
40
|
5281BV
|
APROCIN 0.3% EYE DR (ARP/AHI) CIPROFLOXACIN
|
CIPROFLOXACIN
|
APROCIN
|
10ML
|
BH
|
8.15
|
8.15
|
EYE DROP
|
0
|
BOTT
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2022-09-30
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2022-03-29
|